Monitoring_VBG DPD_NN activity_NN may_MD be_VB important_JJ in_IN the_DT management_NN of_IN patients_NNS experiencing_VBG severe_JJ toxicity_NN secondary_JJ to_TO FUra_NN chemotherapy_NN ._.
